Learn / RLMD
NASDAQ: RLMD
Relmada Therapeutics (RLMD) stock, explained like you're 5
Relmada Therapeutics trades on the Nasdaq under the ticker RLMD. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 362 million dollars.
- Ticker
- RLMD
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations
- Size
- Small cap, about 362 million dollars
Is Relmada Therapeutics a small, medium or large cap company?
No. Relmada Therapeutics is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 362 million dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Relmada Therapeutics makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves RLMD stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- Here's Why Relmada Therapeutics (RLMD) Is a Great 'Buy the Bottom' Stock Now (Yahoo Finance)
- Relmada Therapeutics, Inc.: Revenue and Earnings Analysts Forecasts Revisions | RLMD | US75955J4022 (marketscreener.com)
- RLMD Forecast Price Target Prediction for 2027 (TradingView)
- Full Transcript: Relmada Therapeutics Q2 2026 Earnings Call (Benzinga)
- RLMD Stock Soars Pre Market: Phase 2 Bladder Cancer Trial Data Impresses Investors (Stocktwits)
Follow RLMD in your daily brief
Each trading day at 5 PM ET we post what happened to Relmada Therapeutics and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow RLMD
Questions about Relmada Therapeutics stock
What does Relmada Therapeutics do?
Relmada Therapeutics trades on the Nasdaq under the ticker RLMD. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 362 million dollars.
What is the ticker symbol for Relmada Therapeutics?
Relmada Therapeutics trades under the ticker RLMD on the Nasdaq.
What is Relmada Therapeutics's market cap?
Relmada Therapeutics is a small cap stock with a market cap of about 362 million dollars.
How does Relmada Therapeutics make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves RLMD stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow RLMD stock every day?
Add RLMD to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.